Medidata Solutions (MDSO) Upgraded to “Hold” by BidaskClub
Medidata Solutions (NASDAQ:MDSO) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Tuesday.
Several other research firms have also issued reports on MDSO. Royal Bank of Canada began coverage on shares of Medidata Solutions in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $82.00 price target on the stock. Zacks Investment Research upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, September 20th. SunTrust Banks restated a “buy” rating and issued a $92.00 price target on shares of Medidata Solutions in a research report on Friday, October 27th. Wells Fargo & Co decreased their price target on shares of Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research report on Friday, October 27th. Finally, Dougherty & Co began coverage on shares of Medidata Solutions in a research report on Thursday, November 2nd. They issued a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $84.54.
Medidata Solutions (NASDAQ MDSO) opened at $67.20 on Tuesday. The company has a market cap of $3,930.00, a price-to-earnings ratio of 96.00, a P/E/G ratio of 3.47 and a beta of 1.69. Medidata Solutions has a twelve month low of $47.77 and a twelve month high of $85.92. The company has a quick ratio of 3.37, a current ratio of 1.29 and a debt-to-equity ratio of 0.61.
Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Thursday, October 26th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.31 by $0.02. The firm had revenue of $140.08 million for the quarter, compared to the consensus estimate of $141.27 million. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The business’s quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.28 EPS. analysts expect that Medidata Solutions will post 0.78 earnings per share for the current fiscal year.
In other news, EVP Michael I. Otner sold 10,000 shares of Medidata Solutions stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $70.88, for a total transaction of $708,800.00. Following the sale, the executive vice president now directly owns 80,674 shares in the company, valued at approximately $5,718,173.12. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Rouven Bergmann sold 2,000 shares of Medidata Solutions stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $65.40, for a total transaction of $130,800.00. Following the sale, the chief financial officer now owns 91,775 shares in the company, valued at $6,002,085. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 239,010 shares of company stock worth $16,437,036. 5.80% of the stock is owned by company insiders.
Several institutional investors have recently modified their holdings of MDSO. Fortaleza Asset Management Inc. acquired a new stake in shares of Medidata Solutions during the 3rd quarter valued at about $155,000. Polen Capital Management LLC acquired a new stake in shares of Medidata Solutions during the 3rd quarter valued at about $205,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Medidata Solutions during the 2nd quarter valued at about $227,000. ETF Managers Group LLC acquired a new stake in shares of Medidata Solutions during the 2nd quarter valued at about $233,000. Finally, Hanseatic Management Services Inc. boosted its position in shares of Medidata Solutions by 14,915.0% during the 3rd quarter. Hanseatic Management Services Inc. now owns 3,003 shares of the company’s stock valued at $234,000 after acquiring an additional 2,983 shares in the last quarter.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.